| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Prairie Senior Cottages is a Willmar, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our seasoned hosts will help you find the experience you’re looking for. We’re here to lend a steady hand as you navigate the wondrous world of cannabis.
Monument is an online treatment platform for those looking to change their relationship with alcohol.
CleanCut Technologies is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.